title: Insulin and GH secretion in adolescent girls with irregular cycles: polycystic vs multifollicular ovaries.
abstract: In the present study insulin (I) and GH secretion was studied in a group of twenty-five young adolescent girls (mean age: 15 +/- 0.23 yr) with cycle irregularity associated to clinical signs of hyperandrogenism in comparison with that observed in eleven normal matched subjects with regular menses. All patients underwent basal hormone measurements and, on two consecutive days, an oral glucose tolerance test (OGTT) and a GHRH iv test. Therefore, all subjects had a transabdominal US scan for the measurement of ovarian volume and the characterization of ovarian morphology. On the basis of the US examination we found patients with polycystic ovaries (PCO-like group) and subjects with multifollicular ovaries (MFO group). PCO-like group exhibited T (p<0.01) and LH (p<0.05) plasma levels higher than control group and the highest free androgen index (FAI) values (13 +/- 0.87). All patients with irregular menses showed plasma concentrations of AUC for I (AUC-I) significantly higher in respect to control group (7359.4 +/- 709 vs 5447 +/- 431 microIU/ml x 180 min, p<0.01) as well as both PCO-like group and MFO group did (p<0.001 and p<0.01) respectively. MFO group showed higher values of the AUC for GH (AUC-GH) (2809 +/- 432 ng/ml x 120 min) in respect to controls (1708 +/- 208 ng/ml x 120 min, p<0.05) and PCO-like subjects (p<0.001), who on the contrary showed the lowest AUC-GH values (618 +/- 119 ng/ml x 120 min). In conclusion, PCO-like patients associated hyperinsulinemia with a blunted GH secretion while MFO patients had higher GH secretion associated with higher AUC-I values in a way suggesting an immature and still developing reproductive system.
authors.affiliation: Department of Obstetrics and Gynecology, Università Cattolica del Sacro Cuore, Rome, Italy. paola.villa@glauco.it
authors.forename: P
authors.initials: P
authors.lastname: Villa
authors.forename: A
authors.initials: A
authors.lastname: Rossodivita
authors.forename: A M
authors.initials: AM
authors.lastname: Fulghesu
authors.forename: F
authors.initials: F
authors.lastname: Cucinelli
authors.forename: A
authors.initials: A
authors.lastname: Barini
authors.forename: R
authors.initials: R
authors.lastname: Apa
authors.forename: C
authors.initials: C
authors.lastname: Belosi
authors.forename: A
authors.initials: A
authors.lastname: Lanzone
mesh_terms: D000293:Adolescent; D019540:Area Under Curve; D003937:Diagnosis, Differential; D005260:Female; D005951:Glucose Tolerance Test; D013007:Growth Hormone-Releasing Hormone / Q000502:physiology; D019382:Human Growth Hormone / Q000097:blood*; D006801:Humans; D017588:Hyperandrogenism / Q000097:blood; D006946:Hyperinsulinism / Q000503:physiopathology; D007328:Insulin / Q000097:blood*; D007986:Luteinizing Hormone / Q000097:blood; D008597:Menstrual Cycle / Q000097:blood*; D008599:Menstruation Disturbances / Q000097:blood* / Q000145:classification / Q000000981:diagnostic imaging; D010048:Ovarian Cysts / Q000097:blood* / Q000000981:diagnostic imaging; D010053:Ovary / Q000000981:diagnostic imaging; D011085:Polycystic Ovary Syndrome / Q000097:blood / Q000000981:diagnostic imaging; D013739:Testosterone / Q000097:blood; D014463:Ultrasonography
chemical_list: D007328:Insulin; D019382:Human Growth Hormone; D013739:Testosterone; D007986:Luteinizing Hormone; D013007:Growth Hormone-Releasing Hormone